{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:40:31Z","timestamp":1785436831083,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["305522"],"award-info":[{"award-number":["305522"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11904-016-0324-x","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T02:09:07Z","timestamp":1467166147000},"page":"235-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals"],"prefix":"10.1007","volume":"13","author":[{"given":"Jonathan","family":"Underwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"324_CR1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193\u2013202.","journal-title":"AIDS"},{"key":"324_CR2","first-page":"2087","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology American Academy of Neurology. 2010;75:2087\u201396.","journal-title":"Neurology American Academy of Neurology"},{"key":"324_CR3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","volume":"21","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21:1915\u201321.","journal-title":"AIDS"},{"key":"324_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s13365-012-0094-1","volume":"18","author":"LA Wendelken","year":"2012","unstructured":"Wendelken LA, Valcour V. Impact of HIV and aging on neuropsychological function. J Neurovirol. 2012;18:256\u201363.","journal-title":"J Neurovirol"},{"key":"324_CR5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","volume":"59","author":"J Schouten","year":"2014","unstructured":"Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59:1787\u201397.","journal-title":"Clin Infect Dis"},{"key":"324_CR6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/ciu976","volume":"60","author":"A Winston","year":"2015","unstructured":"Winston A, Amin J, Clarke A, Else L, Amara A, Owen A, et al. Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial. Clin Infect Dis. 2015;60:1026\u201332. Interesting sub-study of the ENCORE study showing the CSF virological efficacy of 400\u00a0mg efavirenz OD and complicated non-dose dependent pharmacokinetics of its metabolite 8-OH that has been shown to exhibit significant neurotoxicity.","journal-title":"Clin Infect Dis"},{"key":"324_CR7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","volume":"202","author":"A Ed\u00e9n","year":"2010","unstructured":"Ed\u00e9n A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, et al. HIV\u20101 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010;202:1819\u201325.","journal-title":"J Infect Dis"},{"key":"324_CR8","doi-asserted-by":"crossref","first-page":"e61738","DOI":"10.1371\/journal.pone.0061738","volume":"8","author":"LA Cysique","year":"2013","unstructured":"Cysique LA, Moffat K, Moore DM, Lane TA, Davies NWS, Carr A, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study. PLoS ONE. 2013;8:e61738.","journal-title":"PLoS ONE"},{"key":"324_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","volume":"29","author":"J Underwood","year":"2015","unstructured":"Underwood J, Robertson KR, Winston A. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS [Internet]. 2015;29:253\u201361.","journal-title":"AIDS [Internet]"},{"key":"324_CR10","unstructured":"Medicine ASFH. HIV Management in Australasia [Internet]. ashm.org.au. 2009 [cited 2016 Jan 11]. Available from: http:\/\/www.ashm.org.au\/resources\/Pages\/HIV-Management-in-Australasia.aspx ."},{"key":"324_CR11","volume-title":"BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy","author":"D Churchill","year":"2015","unstructured":"Churchill D, Waters L, Ahmed N, Angus B, Boffito M. BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy. 2015."},{"key":"324_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","volume":"13","author":"D Asboe","year":"2011","unstructured":"Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2011;13:1\u201344.","journal-title":"HIV Med"},{"key":"324_CR13","unstructured":"EACS Guidelines. 7 ed. Lundgren JD, Gatell JM, Furrer H, Rockstroh J, editors. eacsociety.org. European AIDS Clinical Society (EACS); 2014."},{"key":"324_CR14","unstructured":"EACS Guidelines. 8 ed. Lundgren JD, Ryom L, Gatell JM, Furrer H, Rockstroh J, editors. eacsociety.org. European AIDS Clinical Society (EACS); 2015."},{"key":"324_CR15","doi-asserted-by":"crossref","unstructured":"Hoen B, Bonnet F, Delaugerre C, Delobel P, Goujard C, L\u2019H\u00e9naff M, et al. French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults. J Int AIDS Soc. 2014;17:19034.","DOI":"10.7448\/IAS.17.1.19034"},{"issue":"Suppl 1","key":"324_CR16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1177\/2325957415613442","volume":"14","author":"International Advisory Panel on HIV Care Continuum Optimization","year":"2015","unstructured":"International Advisory Panel on HIV Care Continuum Optimization. IAPAC guidelines for optimizing the HIV care continuum for adults and adolescents. J Int Assoc Provid AIDS Care. 2015;14 Suppl 1:S3\u2013S34.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"324_CR17","doi-asserted-by":"crossref","unstructured":"G\u00fcnthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society\u2013USA Panel. JAMA. 2014;312:410\u201325.","DOI":"10.1001\/jama.2014.8722"},{"key":"324_CR18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cit665","volume":"58","author":"JA Aberg","year":"2013","unstructured":"Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2013;58:e1\u2013e34.","journal-title":"Clin Infect Dis"},{"key":"324_CR19","unstructured":"Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Armignacco O, et al. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. New Microbiol. 2012;35:113\u201359."},{"key":"324_CR20","unstructured":"Antinori A, Marcotullio S, Andreoni M, Ammassari A, d\u2019Arminio Monforte A, Galli M, et al. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014. New Microbiol. 2015;38:299\u2013328."},{"key":"324_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3947\/ic.2015.47.3.205","volume":"47","author":"Korean Society for AIDS","year":"2015","unstructured":"Korean Society for AIDS. The 2015 clinical guidelines for the diagnosis and treatment of HIV\/AIDS in HIV-infected Koreans. Infect Chemother. 2015;47:205\u201311.","journal-title":"Infect Chemother"},{"key":"324_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1155\/2011\/169045","volume":"22","author":"D Rouleau","year":"2011","unstructured":"Rouleau D, Fortin C, Trottier B, Lalonde R, Lapointe N, C\u00f4t\u00e9 P, et al. Antiretroviral therapy for adults infected with HIV: guidelines for health care professionals from the Quebec HIV care committee. Can J Infect Dis Med Microbiol. 2011;22:52\u201360.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"324_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12981-015-0053-z","volume":"12","author":"W Manosuthi","year":"2015","unstructured":"Manosuthi W, Ongwandee S, Bhakeecheep S, Leechawengwongs M, Ruxrungtham K, Phanuphak P, et al. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther. 2015;12:12.","journal-title":"AIDS Res Ther"},{"key":"324_CR24","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2015). Department of Health and Human Services. Available at http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf"},{"key":"324_CR25","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2016). Available from: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf ."},{"key":"324_CR26","unstructured":"World Health Organization. WHO | Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what\u2019s new. WHO. World Health Organization; 2015."},{"key":"324_CR27","volume-title":"Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2014."},{"key":"324_CR28","unstructured":"Geneva: World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization; 2015."},{"key":"324_CR29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/cir524","volume":"53","author":"V Valcour","year":"2011","unstructured":"Valcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011;53:836\u201342. Excellent review focusing on the complexities of screening for cognitive impairment in HIV-positive populations. Useful summary of appropriate screening tools.","journal-title":"Clin Infect Dis"},{"key":"324_CR30","doi-asserted-by":"crossref","unstructured":"Mind Exchange Working Group. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013;56:1004\u201317. Thorough review of the management of HIV-associated cognitive impairment. Again, a useful summary of the pros and cons of potential screening tools.","DOI":"10.1093\/cid\/cis975"},{"key":"324_CR31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789\u201399.","journal-title":"Neurology"},{"key":"324_CR32","doi-asserted-by":"crossref","unstructured":"Lin JS, O\u2019Connor E, Rossom RC, Perdue LA, Eckstrom E. Screening for cognitive impairment in older adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159:601\u201312.","DOI":"10.7326\/0003-4819-159-9-201311050-00730"},{"key":"324_CR33","doi-asserted-by":"crossref","unstructured":"Moyer VA. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:791\u20137.","DOI":"10.7326\/M14-0496"},{"key":"324_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"324_CR35","unstructured":"Centre for Evidence-Based Medicine. [Internet]. cebm.net. [cited 2016 Jan 29]. Available from: http:\/\/www.cebm.net\/category\/ebm-resources\/ ."},{"key":"324_CR36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795\u2013807. Important study demonstrating the benefit of early initiation of antiretroviral therapy that has changed guidelines worldwide.","journal-title":"N Engl J Med"},{"key":"324_CR37","unstructured":"Group GW. Grading the quality of evidence and the strength of recommendations [Internet]. gradeworkinggroup.org. [cited 2016 Jan 29]. Available from: http:\/\/www.gradeworkinggroup.org\/intro.htm ."},{"key":"324_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAD.0000000000000892","volume":"30","author":"TH Evering","year":"2016","unstructured":"Evering TH, Applebaum A, La Mar M, Garmon D, Dorfman D, Markowitz M. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection. AIDS. 2016;30:203\u201310.","journal-title":"AIDS"},{"key":"324_CR39","unstructured":"Wright E, Grund B, Robertson K, Price RW, Group FTISNS. No difference between the effects of immediate versus deferred ART on neuropsychological test performance in HIV-positive adults with CD4+ cell counts above 500 cells\/\u03bcl: the Strategic Timing of Anti-Retroviral Treatment (START) Neurology Substudy. 15th European AIDS Conference. 2015."},{"key":"324_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65\u201370.","journal-title":"Arch Neurol"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-016-0324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-016-0324-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-016-0324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:22:29Z","timestamp":1589674949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-016-0324-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1007\/s11904-016-0324-x","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]}}}